Brain coupling patterns as predictive markers for psychosis in 22q11.2DS

FHS
July 22, 2024
12:11 pm

A UNIGE team shows that overly strong or weak interconnections between certain brain areas could be a predictive marker of the disease.

Ahead of adcomm, FDA questions efficacy of Alnylam’s patisiran in disabling rare condition ATTR-CM

The FDA’s Cardiovascular and Renal Drugs Advisory Committee will meet tomorrow to discuss the efficacy of Alnylam’s Onpattro (patisiran) for the treatment of cardiomyopathy of

September 13, 2023

BetterLife Pharma to Host Investors Update Call on September 18, 2023 | Psychedelic Invest

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic derivative of lysergic acid

September 14, 2023

COVID-19 vaccine rollout phases linked to decreased anxiety and depression in US adults

The various COVID-19 vaccine rollout phases impacted the prevalence of depression and anxiety at the population level among adults in the country.

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.